Nasopharyngeal Cancer Market Growth, Size, Share and Forecast 2018-2023

Nasopharyngeal cancer market is expected to grow at a significant rate during the forecast period 2018-2023. The nasopharynx is the upper part of the throat (pharynx) that lies behind the nose. The nasopharynx cancer or nasopharyngeal carcinoma (NPC) results from abnormal growth of cells in the nasopharynx. It is one of the rare cancer forms globally, ranking as the 27th most frequently diagnosed cancer globally in 2015. The market is expected to show a lucrative market growth rate. Increasing incidence of nasopharyngeal cancer across the globe high tobacco and alcohol consumption are the major factor driving the market during the forecasted period. As per the American Medical Association, the global incident cases of nasopharyngeal cancer in 2015 were more than 123,000 with a growth of 16.5% as compared to 2005. The prevalence of the cancer is in both male and female however male has more prevalence rate. There were 88,000 cases among men in 2015 with an incidence rate of 2.6 per 100,000 whereas it was 35,000 in women with an incidence rate of 0.9 per 100,000. Death rate per 100,000 were 1.4 in men and 0.5 in female. Furthermore, high intake of salt-preserved food and exposure to Epstein-Barr Virus (EBV) are also motivating the market. Almost all people infected with NPC have an infection by EBV virus in their blood. Infection with EBV is very common globally, often occurring in childhood. However, as per the American Cancer Society, the link between EBV infection and NPC is complex and it is not completely understood.

A full report of Global Nasopharyngeal Cancer Market is available at:  https://www.omrglobal.com/industry-reports/nasopharyngeal-cancer-market

There are certain factors that are hindering the growth of the market. The high cost of treatment, low awareness toward cancer and an adverse side effect of treatment are the major restraint of the market. Alcohol and Tabaco consumption are the major cause for NPC however as per American Society of Clinical Oncology about 70% of Americans didn’t know that drinking alcohol is a risk factor for cancer. As per the National Center for Biotechnology Information, the cost of treatment of NPC range from $15,000 to $18,000.

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/nasopharyngeal-cancer-market

The nasopharyngeal cancer market is studied critically by segmenting the market on the basis of cancer type, therapy and by diagnosis method. Mainly there are 3 types of nasopharyngeal cancer that are keratinising squamous cell carcinoma, non-keratinising squamous cell carcinoma, and undifferentiated carcinomas. It is estimated that non-keratinising squamous cell carcinoma will have a major market share in the forecasted period. According to the Canadian Cancer Society, non-keratinising squamous cell carcinoma have 60% share in total NPC. There are two types of diagnosis method. At the initial stage, NPC can be diagnosis by nasendoscopy, panendoscopy, and needle biopsy. For advance diagnosis, CT scan, pet scan, MRI scan, bone scan. A biopsy is estimated to have major market share during 2018-2023. By therapy, the market is divided into chemotherapy, immunotherapy, radiation therapy, and surgery. Radiation therapy is expected to have a major market share in during 2018-2023 as it is the most common treatment. Chemotherapy along with radiation therapy is also expected to use in the near future as it provides better treatment. It is known as chemoradiation.

The global nasopharyngeal cancer market is analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. The market has been segmented into North America, Europe, Asia Pacific and Rest of the World. The Asia Pacific is expected to dominate in the global nasopharyngeal cancer market owing to the high prevalence of nasopharyngeal cancer in South China. This type of cancer is observed in the special ethnicity in China. This cancer is more common in China. According to the Center for Health Protection of Government of Hong Kong in 2015, NPC was the 6th common cancer in men and 14th in women. Large customer base, the continuous increment in economy and healthcare facility are the major factor for the growth of the market in the region. In the financial budget of 2018, the government of India has introduced a national health protection scheme to cover 500 million people by providing them up to $8000 per family per year for secondary and tertiary care hospitalization. It is also expected to raise the healthcare market in the country.

After the Asia Pacific, North America is expected to lead the market in the near future. According to the American Cancer Society, about 3,200 cases were registered in the US in 2015. Near to half of the people with NPC in the US is under 55 years age group.  The prevalence is increasing due to increasing consumption of alcohol, Tabaco and another harmful element. Hence, it is also expected to show a significant growth rate. Europe is expected to show a lucrative growth rate during the forecasted period. In the UK the registered NPC cases were near to 250 on yearly basis.

Global Nasopharyngeal Cancer Market- Segmentation

By Cancer Type

• Keratinising Squamous Cell Carcinoma
• Non-Keratinising Squamous Cell Carcinoma
• Undifferentiated Carcinomas
• Other (Adenocarcinoma and Adenoid Cystic Carcinomas)

By Diagnosis Method

• Initial Diagnosis
• Fine Needle Aspiration/Needle Biopsy

By Therapy

• Chemotherapy
• Immunotherapy
• Surgery
• Targeted Therapy

For more customized data, request for report customization @  https://www.omrglobal.com/report-customization/nasopharyngeal-cancer-market

Global Nasopharyngeal Cancer Market– Segment by Region

North America          

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific   

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Biodiem Ltd.
• Bristol-Myers Squibb
• Cyclacel Pharmaceuticals Inc.
• Eli Lilly And Co.
• GlaxoSmithKline Plc.
• Merck & Co., Inc.
• Novartis International AG
• Ono Pharmaceutical Co.,
• Safoni
• Theravectys SA

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 7803040404